<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04731896</url>
  </required_header>
  <id_info>
    <org_study_id>UTuniselmanar2</org_study_id>
    <nct_id>NCT04731896</nct_id>
  </id_info>
  <brief_title>Early Versus Late Amniotomy During Labor Induction in Women With Bishop's Score of ≥ 6</brief_title>
  <official_title>Early Versus Late Amniotomy During Labor Induction in Women With Bishop's Score of ≥ 6 : a Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Tunis El Manar</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Tunis El Manar</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Labor induction is the stimulation of uterine contractions during pregnancy, before labor&#xD;
      begins on its own to achieve a vaginal birth.&#xD;
&#xD;
      A health care provider might recommend labor induction for various reasons: primarily when&#xD;
      there's concern for a mother's health or a baby's health.&#xD;
&#xD;
      Combined with oxytocin infusion, amniotomy is commonly used in the induction of labor.&#xD;
      However the perfect timing of amniotomy is still unknown.&#xD;
&#xD;
      The aim of this study is to determine whether the early amniotomy followed by oxytocin, or&#xD;
      initiating induction of labor with oxytocin followed by late amniotomy, is effective to reach&#xD;
      active phase of labor.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to active phase of labor</measure>
    <time_frame>At delivery</time_frame>
    <description>Total time from initiation oxytocin infusion to reaching 5 cm cervical dilation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cesarean delivery rate</measure>
    <time_frame>At delivery</time_frame>
    <description>Rate of cesarean section</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to vaginal delivery</measure>
    <time_frame>At delivery</time_frame>
    <description>Total time from initiation of labor induction to vaginal delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal outcomes</measure>
    <time_frame>From inclusion to discharge, up to 2 weeks</time_frame>
    <description>Intrapartum and postpartum fever, postpartum haemorrhage, chorioamnionitis, endometritis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fetal and neonatal outcome</measure>
    <time_frame>From inclusion to discharge, up to 2 weeks</time_frame>
    <description>Fetal distress, birth asphyxia, acidosis, sepsis</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Labor, Induced</condition>
  <condition>Amniotomy</condition>
  <arm_group>
    <arm_group_label>Late Amniotomy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Initiating induction of labor with oxytocin infusion followed by amniotomy 4-6 hours later</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Early Amniotomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Early amniotomy initiating induction of labor followed by oxytocin infusion 30 minutes later</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Amniotomy</intervention_name>
    <description>artificial rupture of the amniotic sac</description>
    <arm_group_label>Early Amniotomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 18 years old&#xD;
&#xD;
          -  Full term (36 weeks and 3 days of gestation reached)&#xD;
&#xD;
          -  Singletion gestation in cephalic presentation&#xD;
&#xD;
          -  Bishop score of ≥ 6&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Prior uterine surgery, previous cesarean section&#xD;
&#xD;
          -  Ruptured membranes&#xD;
&#xD;
          -  Spontaneous labor&#xD;
&#xD;
          -  Multifetal pregnancy&#xD;
&#xD;
          -  Dystocic presentation&#xD;
&#xD;
          -  Fetal head not fixed at pelvic brim&#xD;
&#xD;
          -  Macrosomia&#xD;
&#xD;
          -  Hydramnios&#xD;
&#xD;
          -  Severe fetal growth restriction&#xD;
&#xD;
          -  Major fetal anomaly&#xD;
&#xD;
          -  Women with HIV, hepatitis C, hepatitis B&#xD;
&#xD;
          -  Women with medical conditions contraindication to a vaginal delivery&#xD;
&#xD;
          -  Women with COVID-19 infection&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>48 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ahmed Halouani, MD</last_name>
    <phone>50527325</phone>
    <phone_ext>216</phone_ext>
    <email>ahmed.halouani@fmt.utm.tn</email>
  </overall_contact>
  <location>
    <facility>
      <name>University hospital Mongi Slim la Marsa</name>
      <address>
        <city>Tunis</city>
        <state>La Marsa</state>
        <zip>2046</zip>
        <country>Tunisia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lamia Khalfa</last_name>
      <phone>70109181</phone>
      <phone_ext>216</phone_ext>
      <email>lamiaziko13@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Tunisia</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>January 26, 2021</study_first_submitted>
  <study_first_submitted_qc>January 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 1, 2021</study_first_posted>
  <last_update_submitted>June 25, 2021</last_update_submitted>
  <last_update_submitted_qc>June 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Tunis El Manar</investigator_affiliation>
    <investigator_full_name>Ahmed Halouani</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>labor</keyword>
  <keyword>Amniotomy</keyword>
  <keyword>induction</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>5 years from 01/01/2022</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

